Fort, L.P. Jazz Pharmaceuticals PLC Transaction History

Fort, L.P.

$38.5 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $379,744 - $452,346	-2,682 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $250,853 - $310,954	-1,935 Reduced 41.91%	2,682 $418,000
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $371,597 - $451,576	-3,100 Reduced 40.17%	4,617 $588,000
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $341,281 - $490,247	-2,653 Reduced 25.58%	7,717 $1.01 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $171,253 - $199,282	-1,069 Reduced 9.35%	10,370 $1.84 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $5,557 - $6,419	-37 Reduced 0.32%	11,439 $1.88 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $435,497 - $510,829	3,095 Added 36.93%	11,476 $1.89 Million
Q3 2020 Nov 13, 2020	BUY	$105.46 - $144.13 $441,350 - $603,184	4,185 Added 99.74%	8,381 $1.2 Million
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $380,806 - $485,082	-3,980 Reduced 48.68%	4,196 $463,000
Q1 2020 May 14, 2020	BUY	$87.74 - $152.74 $145,648 - $253,548	1,660 Added 25.48%	8,176 $815,000
Q4 2019 Feb 13, 2020	SELL	$117.65 - $153.73 $355,891 - $465,033	-3,025 Reduced 31.71%	6,516 $973,000
Q3 2019 Nov 13, 2019	SELL	$125.18 - $143.24 $354,634 - $405,798	-2,833 Reduced 22.89%	9,541 $1.22 Million
Q2 2019 Aug 13, 2019	BUY	$125.55 - $144.48 $177,527 - $204,294	1,414 Added 12.9%	12,374 $1.76 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $363,846 - $426,991	2,987 Added 37.46%	10,960 $1.57 Million
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $581,786 - $836,701	5,018 Added 169.81%	7,973 $988,000
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $475,784 - $533,584	2,955 New	2,955 $497,000

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.37B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account